Biotechnology company sought evaluation of the US potential for a novel urology therapeutic.

• Analyzed secondary data to assess patient population and segmentation, treatment algorithms, physician segmentation, standard of care & emerging competitors
• Conducted in depth qualitative interviews with US thought leaders and community physicians to probe market dynamics, unmet needs, drivers, barriers, TPP reaction & prescribing considerations
• Generated topline US revenue forecast
• Synthesized findings and recommendations

• Advised client concerning value proposition and revenue forecast considerations
• Client used output to inform its investment strategy and specific deal terms for this opportunity